Figure 2.
Survival analysis after the development of cutaneous metastasis in all cancer patients, with median overall survival of 9.21 months (95% confidence interval, 4.75–83.38 months).
Survival analysis after the development of cutaneous metastasis in all cancer patients, with median overall survival of 9.21 months (95% confidence interval, 4.75–83.38 months).